Ahad Azimuddin
Appearances
- DateMay 9, 2023Long-term survival in patients with localized pancreatic adenocarcinoma (PDAC) or ampullary adenocarcinoma (AA) who undergo resection is rare, even in lymph node (LN)-negative disease…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterU.T. MD Anderson Cancer CenterUniv. Texas MD Anderson Cancer CenterBrody School of Medicine at ECU - DateMay 9, 2023Long-term survival in patients with localized pancreatic adenocarcinoma (PDAC) or ampullary adenocarcinoma (AA) who undergo resection is rare, even in lymph node (LN)-negative disease…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterMD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center - DateMay 9, 2023Background: Sarcomas are rare mesenchymal tumors with a propensity for hematogenous metastasis, leading to liver metastasis. Advancements in liver surgery have led to increased resection of sarcomatous liver metastasis as discussed in several studies…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterMD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center - DateMay 9, 2023Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterU.T. MD Anderson Cancer CenterUniv. Texas MD Anderson Cancer CenterBrody School of Medicine at ECU - DateMay 6, 2023LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterU.T. MD Anderson Cancer CenterUniv. Texas MD Anderson Cancer CenterBrody School of Medicine at ECU - DateMay 19, 2024Formerly validated risk-stratified pancreatectomy clinical pathways decreased index hospitalization stay without increasing readmissions, which remain major contributors to the financial burden of pancreatectomy…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterBrody School of Medicine at ECUU.T. MD Anderson Cancer Center
